{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:49:58Z","timestamp":1792162198675,"version":"4.4.0"},"reference-count":93,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd016403","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:25:15Z","timestamp":1792160715000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Statins for adults with a first episode of venous thromboembolic disease"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0879-4444","authenticated-orcid":false,"given":"H\u00e9ctor Jos\u00e9","family":"Peroni","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"},{"name":"Medical-Surgical Department; Mar\u00eda Ferrer Respiratory Rehabilitation Hospital; Ciudad Aut\u00f3noma de Buenos Aires, Argentina. Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Rico","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Micaela","family":"Escobar Liquitay","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garegnani","sequence":"additional","affiliation":[{"name":"Cochrane Associate Centre; Universidad Hospital Italiano de Buenos Aires; Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Scientific Reports"},{"issue":"11","key":"10.1002\/14651858.CD016403-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1161\/atvbaha.114.304488","article-title":"Thrombosis","volume":"34","author":"Raskob","year":"2014","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"8","key":"10.1002\/14651858.CD016403-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nature Reviews Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD016403-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/atvbaha.124.320151","article-title":"Global health burden of venous thromboembolism","volume":"44","author":"Wendelboe","year":"2024","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"11","key":"10.1002\/14651858.CD016403-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.7326\/0003-4819-140-11-200406010-00007","article-title":"Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis","volume":"140","author":"B\u00fcller","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD016403-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1056\/nejmoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD016403-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/nejmoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"15","key":"10.1002\/14651858.CD016403-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1056\/nejmoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jth.14364","article-title":"Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial","volume":"17","author":"Orsi","year":"2019","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"3","key":"10.1002\/14651858.CD016403-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.7326\/0003-4819-140-3-200402030-00008","article-title":"Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism","volume":"140","author":"Quinlan","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0011|cit11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001100.pub4","article-title":"Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism","author":"Robertson","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1002\/14651858.CD016403-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1056\/nejmoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD016403-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"e41268","DOI":"10.7759\/cureus.41268","article-title":"Low-molecular-weight heparin versus warfarin in adult cancer patients as a precision medicine for thrombosis: a systematic review and meta-analysis","volume":"15","author":"Zaki","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"10.1002\/14651858.CD016403-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1111\/jth.14239","article-title":"Substantial recurrence risk after venous thromboembolism provoked by minor risk factors","volume":"16","author":"Br\u00e6kkan","year":"2018","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD016403-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/5584_2016_126","article-title":"Post thrombotic syndrome","volume":"906","author":"Busuttil","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"9920","key":"10.1002\/14651858.CD016403-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/s0140-6736(13)61902-9","article-title":"Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11883-025-01386-9","article-title":"Pleiotropic effects of statins: focus on inflammation, oxidative stress and immunomodulation (part I)","volume":"28","author":"Mahmoudi","year":"2026","journal-title":"Current Atherosclerosis Reports"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11883-025-01385-w","article-title":"Pleiotropic effects of statins: focus on endothelial function, plaque stability and thrombosis (part II)","volume":"28","author":"Mahmoudi","year":"2026","journal-title":"Current Atherosclerosis Reports"},{"issue":"5","key":"10.1002\/14651858.CD016403-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1200\/jco.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-022-00336-y","article-title":"Cancer-associated venous thromboembolism","volume":"8","author":"Khorana","year":"2022","journal-title":"Nature Reviews Disease Primers"},{"issue":"9","key":"10.1002\/14651858.CD016403-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1042\/cs20100476","article-title":"Aging and vascular endothelial function in humans","volume":"120","author":"Seals","year":"2011","journal-title":"Clinical Science"},{"issue":"10","key":"10.1002\/14651858.CD016403-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/circulationaha.114.009107","article-title":"30-year mortality after venous thromboembolism","volume":"130","author":"S\u00f8gaard","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/jama.286.1.64","article-title":"Effect of statin therapy on C-reactive protein levels","volume":"286","author":"Albert","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1161\/01.atv.0000151647.14923.ec","article-title":"Statins and blood coagulation","volume":"25","author":"Undas","year":"2005","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"10","key":"10.1002\/14651858.CD016403-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/eurheartj\/ehp556","article-title":"Statins, fibrates, and venous thromboembolism: a meta-analysis","volume":"31","author":"Squizzato","year":"2009","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1016\/s2352-3026(16)30184-3","article-title":"Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis","volume":"4","author":"Kunutsor","year":"2017","journal-title":"Lancet Haematology"},{"issue":"11","key":"10.1002\/14651858.CD016403-BIB0027|cit27","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014769.pub2","article-title":"Statins for the primary prevention of venous thromboembolism","author":"Wang","year":"2024","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD016403-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/jth.12814","article-title":"Inflammation markers and their trajectories after deep vein thrombosis in relation to risk of post-thrombotic syndrome","volume":"13","author":"Rabinovich","year":"2015","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"6","key":"10.1002\/14651858.CD016403-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/fjc.0b013e31804a5e34","article-title":"Rosuvastatin suppresses the inflammatory responses through inhibition of C-JUN N-terminal kinase and nuclear factor-KB in endothelial cells","volume":"49","author":"Kim","year":"2007","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD016403-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.thromres.2022.03.014","article-title":"Prevention of post-thrombotic syndrome with rosuvastatin: a multicenter randomized controlled pilot trial (SAVER)","volume":"213","author":"Delluc","year":"2022","journal-title":"Thrombosis Research"},{"issue":"4","key":"10.1002\/14651858.CD016403-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jtha.2022.12.008","article-title":"Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis","volume":"21","author":"Caiano","year":"2023","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1002\/14651858.CD016403-BIB0032|cit32","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology https:\/\/atcddd.fhi.no\/atc_ddd_index\/?code=C10AA"},{"issue":"9","key":"10.1002\/14651858.CD016403-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"e1001310","DOI":"10.1371\/journal.pmed.1001310","article-title":"Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials","volume":"9","author":"Rahimi","year":"2012","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD016403-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"106931","DOI":"10.1016\/j.vph.2021.106931","article-title":"Effects of statins in primary and secondary prevention for venous thromboembolism events: a meta analysis","volume":"142","author":"Zhu","year":"2022","journal-title":"Vascular Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD016403-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.24875\/acm.20000341","article-title":"Efecto de las estatinas en el desarrollo de s\u00edndrome postromb\u00f3tico: estudio de cohorte","volume":"90","author":"Peroni","year":"2020","journal-title":"Archivos de Cardiolog\u00eda de M\u00e9xico"},{"issue":"20","key":"10.1002\/14651858.CD016403-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/eurheartj\/ehx107","article-title":"Statins and secondary prevention of venous thromboembolism: pooled analysis of published observational cohort studies","volume":"38","author":"Kunutsor","year":"2017","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD016403-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/5584_2016_121","article-title":"Venous and arterial thrombosis: is there a link?","volume":"906","author":"Prandoni","year":"2016","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"38\u201381","DOI":"10.1161\/atv.0000000000000073","article-title":"Statin safety and associated adverse events: a scientific statement from the American Heart Association","volume":"39","author":"Newman","year":"2019","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"10529","key":"10.1002\/14651858.CD016403-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0140-6736(25)01578-8","article-title":"Assessment of adverse effects attributed to statin therapy in product labels: a meta-analysis of double-blind randomised controlled trials","volume":"407","author":"Reith","year":"2026","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD016403-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"766","DOI":"10.7326\/0003-4819-147-11-200712040-00007","article-title":"The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism","volume":"147","author":"Douketis","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"f5133","DOI":"10.1136\/bmj.f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD016403-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.thromres.2012.08.296","article-title":"Lipid lowering drugs and the risk of recurrent venous thromboembolism","volume":"130","author":"Delluc","year":"2012","journal-title":"Thrombosis Research"},{"key":"10.1002\/14651858.CD016403-BIB0043|cit43","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological expectations of Cochrane intervention reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD016403-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016403-BIB0045|cit45","unstructured":"Higgins JP Eldridge S Li T Chapter 23: Including variants on randomized trials (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016403-BIB0046|cit46","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"19","key":"10.1002\/14651858.CD016403-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Advances"},{"issue":"13","key":"10.1002\/14651858.CD016403-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.jacc.2025.11.005","article-title":"2026 AHA\/ACC\/ACCP\/ACEP\/CHEST\/SCAI\/SHM\/SIR\/SVM\/SVN guideline for the evaluation and management of acute pulmonary embolism in adults","volume":"87","author":"Creager","year":"2026","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1161\/circresaha.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circulation Research"},{"key":"10.1002\/14651858.CD016403-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rce.2020.05.009","article-title":"Tratamiento de la trombosis venosa profunda de extremidades inferiores","volume":"220","author":"Trujillo Santos","year":"2020","journal-title":"Revista Cl\u00ednica Espa\u00f1ola"},{"issue":"9621","key":"10.1002\/14651858.CD016403-BIB0051|cit51","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/s0140-6736(08)60594-2","article-title":"Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial","volume":"371","author":"Righini","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD016403-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.thromres.2024.04.016","article-title":"Modern imaging of acute pulmonary embolism","volume":"238","author":"De Jong","year":"2024","journal-title":"Thrombosis Research"},{"issue":"5","key":"10.1002\/14651858.CD016403-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2967\/jnumed.106.039438","article-title":"Ventilation-perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension","volume":"48","author":"Tunariu","year":"2007","journal-title":"Journal of Nuclear Medicine"},{"issue":"18","key":"10.1002\/14651858.CD016403-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.3390\/jcm12185896","article-title":"Epidemiology and diagnosis of post-thrombotic syndrome: qualitative synthesis with a systematic review","volume":"12","author":"Mangwani","year":"2023","journal-title":"Journal of Clinical Medicine"},{"issue":"2","key":"10.1002\/14651858.CD016403-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MEDDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Safety"},{"issue":"5","key":"10.1002\/14651858.CD016403-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"102965","DOI":"10.1016\/j.rpth.2025.102965","article-title":"Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2","volume":"9","author":"Kobayashi","year":"2025","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"issue":"9","key":"10.1002\/14651858.CD016403-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"10","key":"10.1002\/14651858.CD016403-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.1016\/s1470-2045(19)30336-5","article-title":"2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncology"},{"key":"10.1002\/14651858.CD016403-BIB0059|cit59","unstructured":"WHOQOL: Measuring Quality of Life https:\/\/www.who.int\/tools\/whoqol"},{"issue":"6","key":"10.1002\/14651858.CD016403-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0212-6567(01)70406-4","article-title":"El EuroQol-5D: una alternativa sencilla para la medici\u00f3n de la calidad de vida relacionada con la salud en atenci\u00f3n primaria","volume":"28","author":"Herdman","year":"2001","journal-title":"Atenci\u00f3n Primaria"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12955-015-0227-3","article-title":"Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke","volume":"13","author":"Kim","year":"2015","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12955-015-0227-3","article-title":"Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke","volume":"13","author":"Kim","year":"2015","journal-title":"Health and Quality of Life Outcomes"},{"issue":"7","key":"10.1002\/14651858.CD016403-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1358\/mf.2002.24.7.696544","article-title":"Quality of life (Spain and France): validation of the Chronic Venous Insufficiency Questionnaire (CIVIQ)","volume":"24","author":"Lozano","year":"2002","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD016403-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"e8149","DOI":"10.5867\/medwave.2021.03.8149","article-title":"Minimal clinically important difference: the basics","volume":"21","author":"Salas Apaza","year":"2021","journal-title":"Medwave"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health and Quality of Life Outcomes"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1741-7015-12-109","article-title":"Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform","volume":"12","author":"Tran","year":"2014","journal-title":"BMC Medicine"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12913-017-2031-8","article-title":"Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework","volume":"17","author":"Sekhon","year":"2017","journal-title":"BMC Health Services Research"},{"issue":"18","key":"10.1002\/14651858.CD016403-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/cir.0000000000000130","article-title":"The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies","volume":"130","author":"Kahn","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11239-015-1317-0","article-title":"Guidance for the treatment of deep vein thrombosis and pulmonary embolism","volume":"41","author":"Streiff","year":"2016","journal-title":"Journal of Thrombosis and Thrombolysis"},{"key":"10.1002\/14651858.CD016403-BIB0070|cit70","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies (chapter last updated March 2025). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1. Cochrane, 2025 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016403-BIB0071|cit71","unstructured":"Covidence Veritas Health Innovation 2026"},{"key":"10.1002\/14651858.CD016403-BIB0072|cit72","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2025"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD016403-BIB0074|cit74","unstructured":"Welch VA Petkovic J Jull J Hartling L Klassen T Kristjansson E Chapter 16: Equity and specific populations (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"3","key":"10.1002\/14651858.CD016403-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","article-title":"Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide","volume":"348","author":"Hoffmann","year":"2014","journal-title":"BMJ"},{"issue":"366","key":"10.1002\/14651858.CD016403-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016403-BIB0077|cit77","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016403-BIB0078|cit78","unstructured":"Li T Higgins JP Deeks JJ Chapter 5: Collecting data (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016403-BIB0079|cit79","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect (chapter last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook 2023"},{"key":"10.1002\/14651858.CD016403-BIB0080|cit80","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0081|cit81","doi-asserted-by":"publisher","first-page":"c365","DOI":"10.1136\/bmj.c365","article-title":"The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews","volume":"340","author":"Kirkham","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD016403-BIB0082|cit82","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD016403-BIB0083|cit83","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (chapter last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD016403-BIB0084|cit84","unstructured":"McKenzie JE Chapter 12: Synthesizing and presenting findings using other methods (chapter last updated October 2019). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5 (updated August 2024). Cochrane, 2024 Available from https:\/\/www.training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD016403-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/jth.15626","article-title":"Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: a randomized controlled trial","volume":"20","author":"Ramberg","year":"2022","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"8","key":"10.1002\/14651858.CD016403-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s11239-025-03225-9","article-title":"Thrombosis in patients with cancer: challenges and advances","volume":"58","author":"Koo","year":"2025","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"29","key":"10.1002\/14651858.CD016403-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.1200\/jco.2009.22.3271","article-title":"Assessing risk of venous thromboembolism in the patient with cancer","volume":"27","author":"Khorana","year":"2009","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD016403-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2021.02.015","article-title":"Venous thromboembolism and risk of cancer in users of statins: a Danish population-based cohort study","volume":"201","author":"Skajaa","year":"2021","journal-title":"Thrombosis Research"},{"issue":"11","key":"10.1002\/14651858.CD016403-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"e005862","DOI":"10.1136\/bmjopen-2014-005862","article-title":"The association of statin use with reduced incidence of venous thromboembolism: a population-based cohort study","volume":"4","author":"Lassila","year":"2014","journal-title":"BMJ Open"},{"issue":"19","key":"10.1002\/14651858.CD016403-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1093\/eurheartj\/ehy014","article-title":"Rosuvastatin use improves measures of coagulation in patients with venous thrombosis","volume":"39","author":"Biedermann","year":"2018","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD016403-BIB0091|cit91","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for Grading the Quality of Evidence and the Strength of Recommendations using the GRADE Approach (updated October 2013). GRADE Working Group, 2013 Available from https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD016403-BIB0092|cit92","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2026"},{"key":"10.1002\/14651858.CD016403-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.jclinepi.2019.10.014","article-title":"GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions","volume":"119","author":"Santesso","year":"2020","journal-title":"Journal of Clinical Epidemiology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:25:20Z","timestamp":1792160720000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD016403"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":93,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd016403","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]}}}